Pancreatic cancer is likely to become the second most frequent cause of cancer-associated
mortality within the next decade. Surgical resection with adjuvant systemic chemotherapy …

Objective: To depict and analyze learning curves for open, laparoscopic, and robotic
pancreatoduodenectomy (PD) and distal pancreatectomy (DP). Background: Formal training …

Background Early recognition and management of postoperative complications, before they
become clinically relevant, can improve postoperative outcomes for patients, especially for …

Objective: The aim of this study was to develop a classification system for pancreas-
associated risk factors in pancreatoduodenectomy (PD). Summary Background Data …

The first pancreaticoduodenectomy was performed in 1909 by Dr Kausch. 1 The procedure
was adapted and popularized by Dr Allen Oldfather Whipple in 1935, who performed only …

Objective: To develop 2 distinct preoperative and intraoperative risk scores to predict
postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP) to improve …

Objective: The aim of the study was to validate and optimize the alternative Fistula Risk
Score (a-FRS) for patients undergoing minimally invasive pancreatoduodenectomy (MIPD) …

Objective: To assess short-term outcomes after minimally invasive (laparoscopic, robot-
assisted, and hybrid) pancreatoduodenectomy (MIPD) versus open …

Importance In the past decade, the use of neoadjuvant therapy (NAT) has increased for
patients with borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC) …

Objective: To evaluate TP as an alternative to PD in patients at high-risk for popf.
Background: Outcomes of high-risk PD (HR-PD) and TP have never been compared …